Relationship between transient severe motion of the liver in Gadoxetic acid (cas 135326-11-3) or iodinated contrast agent-enhanced imaging and arterial oxygen saturation and heart rate changes
-
Add time:08/11/2019 Source:sciencedirect.com
PurposeTo clarify the relationship between transient sever motion artifact in arterial phase (TSMA) and changes in peripheral capillary oxygen saturation (SpO2) and heart rate (HR) after contrast media administration during MRI or CT of the liver.
We also recommend Trading Suppliers and Manufacturers of Gadoxetic acid (cas 135326-11-3). Pls Click Website Link as below: cas 135326-11-3 suppliers
Prev:Gadoxetic acid (cas 135326-11-3)-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase
Next:Gadoxetic acid (cas 135326-11-3)-enhanced dynamic magnetic resonance imaging using optimized integrated combination of compressed sensing and parallel imaging technique) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Liver enhancement in healthy dogs after Gadoxetic acid (cas 135326-11-3) administration during dynamic contrast-enhanced magnetic resonance imaging08/19/2019
- Association between non-hypervascular hypointense nodules on Gadoxetic acid (cas 135326-11-3)-enhanced MRI and liver stiffness or hepatocellular carcinoma08/18/2019
- Quantitative analysis of Gadoxetic acid (cas 135326-11-3)-enhanced magnetic resonance imaging predicts histological grade of hepatocellular carcinoma08/17/2019
- Gadoxetic acid (cas 135326-11-3)-enhanced high temporal-resolution hepatic arterial-phase imaging with view-sharing technique: Impact on the LI-RADS category08/16/2019
- T1 mapping on Gadoxetic acid (cas 135326-11-3)-enhanced MR imaging predicts recurrence of hepatocellular carcinoma after hepatectomy08/15/2019
- Biliary tract enhancement in Gadoxetic acid (cas 135326-11-3)-enhanced MRI correlates with liver function biomarkers08/14/2019
- Avoiding Pitfalls in the Interpretation of Gadoxetic acid (cas 135326-11-3)–Enhanced Magnetic Resonance Imaging08/13/2019
- Gadoxetic acid (cas 135326-11-3)-enhanced dynamic magnetic resonance imaging using optimized integrated combination of compressed sensing and parallel imaging technique08/12/2019
- Gadoxetic acid (cas 135326-11-3)-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase08/10/2019
-
Health and Chemical more >